Reduction in Insulin Dose Following Shift from Biphasic Human Insulin to Biphasic Insulin Aspart30/70: Experience from Indian-Cohort of IMPROVE™ Study

被引：0
|
作者：
Shah, Siddharth
Banerjee, Samar
Lamba, P. S.
Chakkarwar, Praful N.
Prusty, Vinay
Moharana, Ashok Kumar
Mazumdar, Anirban
机构：
来源：
DIABETES | 2009年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A534 / A535
页数：2
相关论文
共 50 条
  • [31] Dosing recommendations for biphasic insulin aspart 30 (BIAsp30), insulin detemir (lDet) and insulin aspart (IAsp) from the PREFER treat-to-target study
    Liebl, A.
    Compion, G.
    Prager, R.
    Binz, K.
    Kaiser, M.
    Gallwitz, B.
    [J]. DIABETIC MEDICINE, 2007, 24 : 75 - 75
  • [32] Therapy with biphasic insulin aspart 30/70 (NovoMix 30) improves glycemic control in patients with type 2 diabetes mellitus: results from a Russian cohort of IMPROVE observational program designed to study safety and efficiency of biphasic insulin aspart 30 in routine clinical practice
    Shestakova, M. V.
    Akil, Ballan
    [J]. DIABETES MELLITUS, 2010, 13 (01): : 92 - 100
  • [33] IMPROVE (TM) observational study of biphasic insulin aspart 30/70 in patients with Type 2 diabetes mellitus
    Kawamori, Ryuzo
    Valensi, Paul
    [J]. EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2010, 5 (04) : 507 - 516
  • [34] PROJECTED COST-EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30 IN TYPE 2 DIABETES PATIENTS SWITCHED FROM BIPHASIC HUMAN INSULIN IN THE UNITED STATES
    Aagren, M.
    Thomsen, T. L.
    Knudsen, V. K.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A10 - A10
  • [35] Safety and Effectiveness of Switching from a Basal-only to Biphasic Insulin Aspart 30 Insulin Regimen
    Jihad Haddad
    Mohsen Khoshniatnikoo
    Youcef Benabbas
    Serdar Guler
    Vinay Prusty
    Pradana Soewondo
    [J]. Diabetes Therapy, 2013, 4 : 309 - 319
  • [36] Safety and Effectiveness of Switching from a Basal-only to Biphasic Insulin Aspart 30 Insulin Regimen
    Haddad, Jihad
    Khoshniatnikoo, Mohsen
    Benabbas, Youcef
    Guler, Serdar
    Prusty, Vinay
    Soewondo, Pradana
    [J]. DIABETES THERAPY, 2013, 4 (02) : 309 - 319
  • [37] COST EFFECTIVENESS ANALYSIS OF SWITCHING PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES TO BIPHASIC INSULIN ASPART 30 FROM BIPHASIC HUMAN INSULIN 30 IN THE CZECH SETTING
    Suchankova, E.
    Dolezal, T.
    Pisarikova, Z.
    Rychna, K.
    Bartaskova, D.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A405 - A406
  • [38] Biphasic Insulin Aspart 30/70 (BIAsp 30) Is Well Tolerated Effective in Patients ≥75 Years Old in the IMPROVE™ Study
    Borzi, Vito
    Rosenberg, Kristine Horn
    Benroubi, Marian
    [J]. DIABETES, 2010, 59 : A554 - A555
  • [39] The PREFER study: Dosing recommendations for biphasic insulin aspart 30, insulin detemir and insulin aspart using treat-to-target titration
    Gallwitz, B.
    Prager, R.
    Kaiser, M.
    Binz, K.
    Liebl, A.
    [J]. DIABETOLOGIA, 2006, 49 : 611 - 612
  • [40] 15 Years of Experience with Biphasic Insulin Aspart 30 in Type 2 Diabetes
    Liebl, Andreas
    Mohan, Viswanathan
    Yang, Wenying
    Strojek, Krzysztof
    Linjawi, Sultan
    [J]. DRUGS IN R&D, 2018, 18 (01) : 27 - 39
12345